Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: Significance of left ventricular hypertrophy

Journal of the American College of Cardiology

Volumn 35, Issue 5, 2000, Pages 1237-1244

  Quiñones, Miguel A ^a   Greenberg, Barry H ^b   Kopelen, Helen A ^a,b,c,d,e,f   Koilpillai, Chris ^c   Limacher, Marian C ^d   Shindler, Daniel M ^e   Shelton, Brent J ^f   Weiner, Debra H ^a,b,c,d,e,f  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c DALHOUSIE UNIVERSITY   (Canada)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENALAPRIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DEATH; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE SIZE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SYSTOLE; TREATMENT OUTCOME;

AGED; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PATIENT ADMISSION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0342804535     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00511-8     Document Type: Article

References (56)

1. Bourassa M.G., Gurne O., Bangdiwala S.I., et al. Natural history and patterns of current practice in heart failure the Studies of Left Ventricular Dysfunction (SOLVD) investigators . J Am Coll Cardiol. 22:(supplA):1993;14A-19A.
2. Komajda M., Jais J.P., Reeves F., et al. Factors predicting mortality in idiopathic dilated cardiomyopathy. Eur Heart J. 11:1990;824-831.
3. Cintron G., Johnson G., Francis G., Cobb F., Cohn J.N. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure the V-HeFT VA Cooperative Studies Group . Circulation. 87:(suppl):1993;VI17-VI23.
4. Parameshwar J., Keegan J., Sparrow J., Sutton G.C., Poole-Wilson P.A. Predictors of prognosis in severe chronic heart failure. Am Heart J. 123:1992;421-426.
5. St. John Sutton M., Pfeffer M.A., Plappert T., et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction the protective effects of captopril . Circulation. 89:1994;68-75.
6. Rihal C.S., Nishimura R.A., Hatle L.K., Bailey K.R., Tajik A.J. Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy relation to symptoms and prognosis . Circulation. 90:1994;2772-2779.
7. Xie G.Y., Berk M.R., Smith M.D., Gurley J.C., DeMaria A.N. Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure. [see comments] J Am Coll Cardiol. 24:1994;132-139.
8. Giannuzzi P., Temporelli P.L., Bosimini E., et al. Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction. J Am Coll Cardiol. 28:1996;383-390.
9. Szlachcic J., Massie B.M., Kramer B.L., Topic N., Tubau J. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol. 55:1985;1037-1042.
10. Abramson S.V., Burke J.F., Kelly J.J. Jr, et al. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med. 116:1992;888-895.
11. De Maria R., Gavazzi A., Caroli A., Ometto R., Biagini A., Camerini F. Ventricular arrhythmias in dilated cardiomyopathy as an independent prognostic hallmark Italian Multicenter Cardiomyopathy Study (SPIC) group . Am J Cardiol. 69:1992;1451-1457.
12. Packer M., Lee W.H., Kessler P.D., Gottlieb S.S., Bernstein J.L., Kukin M.L. Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure. [review] Circulation. 75:(pt 2):1987;IV80-IV92.
13. Levy D., Garrison R.J., Savage D.D., Kannel W.B., Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. [see comments] N Engl J Med. 322:1990;1561-1566.
14. Casale P.N., Devereux R.B., Milner M., et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med. 105:1986;173-178.
15. Devereux R.B., de Simone G., Ganau A., Koren M.J., Roman M.J. Left ventricular hypertrophy associated with hypertension and its relevance as a risk factor for complications. [review] J Cardiovasc Pharmacol. 21:(suppl2):1993;S38-S44.
16. Ghali J.K., Kadakia S., Cooper R.S., Liao Y.L. Impact of left ventricular hypertrophy on ventricular arrhythmias in the absence of coronary artery disease. J Am Coll Cardiol. 17:1991;1277-1282.
17. Cooper R.S., Simmons B.E., Castaner A., Santhanam V., Ghali J., Mar M. Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed. Am J Cardiol. 65:1990;441-445.
18. Ghali J.K., Liao Y., Simmons B., Castaner A., Cao G., Cooper R.S. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med. 117:1992;831-836.
19. Sullivan J.M., Vander Zwaag R.V., el-Zeky F., Ramanathan K.B., Mirvis D.M. Left ventricular hypertrophy effect on survival . J Am Coll Cardiol. 22:1993;508-513.
20. Carabello B.A., Nakano K., Corin W., Biederman R., Spann J.F. Jr. Left ventricular function in experimental volume overload hypertrophy. Am J Physiol. 256:1989;H974-H981.
21. Devereux R.B., de Simone G., Ganau A., Roman M.J. Left ventricular hypertrophy and geometric remodeling in hypertension stimuli, functional consequences and prognostic implications . [review] J Hypertens. 12:1994;S117-S127.
22. de Simone G., Devereux R.B., Roman M.J., Ganau A., Saba P.S., Alderman M.H. Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol. 23:1994;1444-1451.
23. Kumpuris A.G., Quiñones M.A., Waggoner A.D., Kanon D.J., Nelson J.G., Miller R.R. Importance of preoperative hypertrophy, wall stress and end-systolic dimension as echocardiographic predictors of normalization of left ventricular dilatation after valve replacement in chronic aortic insufficiency. Am J Cardiol. 49:1982;1091-1100.
24. Studies of left ventricular dysfunction (SOLVD) - rationale, design and methods two trials that evaluate the effect of enalapril in patients with reduced ejection fraction . Am J Cardiol. 66:1990;315-322.
25. Bangdiwala S.I., Weiner D.H., Bourassa M.G., Friesinger G.C. II, Ghali J.K., Yusuf S. Studies of Left Ventricular Dysfunction (SOLVD) Registry rationale, design, methods and description of baseline characteristics . Am J Cardiol. 70:1992;347-353.
26. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 325:1991;293-302.
27. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 327:1992;685-691.
28. Greenberg B., Quiñones M.A., Koilpillai C., et al. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction results of the SOLVD echocardiography substudy . Circulation. 91:1995;2573-2581.
29. Koilpillai C., Quiñones M.A., Greenberg B., et al. Relation of ventricular size and function to heart failure status and ventricular dysrhythmia in patients with severe left ventricular dysfunction. Am J Cardiol. 77:1996;606-611.
30. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms . J Am Soc Echocardiog. 2:1989;358-367.
31. Quiñones M.A., Waggoner A.D., Reduto L.A., et al. A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation. 64:1981;744-753.
32. Enriquez-Sarano M., Tajik A.J., Schaff H.V., et al. Echocardiographic prediction of left ventricular function after correction of mitral regurgitation results and clinical implications . J Am Coll Cardiol. 24:1994;1536-1543.
33. Van Reet R.E., Quiñones M.A., Poliner L.R., et al. Comparison of two-dimensional echocardiography with gated radionuclide ventriculography in the evaluation of global and regional left ventricular function in acute myocardial infarction. J Am Coll Cardiol. 3:(pt 1):1984;243-252.
34. Bonow R.O., Picone A.L., McIntosh C.L., et al. Survival and functional results after valve replacement for aortic regurgitation from 1976 to 1983 impact of preoperative left ventricular function . Circulation. 72:1985;1244-1256.
35. de Simone G., Devereux R.B., Koren M.J., Mensah G.A., Casale P.N., Laragh J.H. Midwall left ventricular mechanics an independent predictor of cardiovascular risk in arterial hypertension . Circulation. 93:1996;259-265.
36. White H.D., Norris R.M., Brown M.A., Brandt P.W., Whitlock R.M., Wild C.J. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 76:1987;44-51.
37. Borow K.M., Green L.H., Mann T., et al. End-systolic volume as a predictor of postoperative left ventricular performance in volume overload from valvular regurgitation. Am J Med. 68:1980;655-663.
38. Teichholz L.E., Kreulen T., Herman M.V., Gorlin R. Problems in echocardiographic volume determination echocardiographic angiographic correlations in the presence or absence of asynergy . Am J Cardiol. 37:1976;7-10.
39. Quiñones M.A., Pickering E., Alexander J.K. Percentage of shortening of the echocardiographic left ventricular dimension its use in determining ejection fraction and stroke volume . Chest. 74:1978;59-65.
40. Francis G.S., McDonald K.M. Left ventricular hypertrophy an initial response to myocardial injury . [review] Am J Cardiol. 69:1992;3G-7G44.
41. Weber K.T., Brilla C.G. Pathological hypertrophy and cardiac interstitium fibrosis and renin-angiotensin-aldosterone system . Circulation. 83:1991;1849-1865.
42. Parker T.G., Packer S.E., Schneider M.D. Peptide growth factors can provoke 'fetal' contractile protein gene expression in rat cardiac myocytes. J Clin Invest. 85:1990;507-514.
43. Schneider M.D., Parker T.G. Cardiac growth factors. Prog Growth Factor Res. 3:1991;1-26.
44. Schunkert H., Hense H.W., Holmer S.R., et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med. 330:1994;1634-1638.
45. Weber K.T., Janicki J.S., Shroff S.G., et al. Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circulation Res. 62:1988;757-765.
46. Doering C.W., Jalil J.E., Janicki J.S., et al. Collagen network remodeling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovasc Res. 22:1988;686-695.
47. Vatner S.F., Shannon R., Hittinger L. Reduced subendocardial coronary reserve a potential mechanism for impaired diastolic function in the hypertrophied and failing heart . Circulation. 81:1990;III8-III14.
48. Weiss M.B., Ellis K., Sciacca R.R., Johnson L.L., Schmidt D.H., Cannon P.J. Myocardial blood flow in congestive and hypertrophic cardiomyopathy relationship to peak wall stress and mean velocity of circumferential fiber shortening . Circulation. 54:1976;484-494.
49. Karam R., Healy B.P., Wicker P. Coronary reserve is depressed in postmyocardial infarction reactive cardiac hypertrophy. Circulation. 81:1990;238-246.
50. Wangler R.D., Peters K.G., Marcus M.L., Tomanek R.J. Effects of duration and severity of arterial hypertension and cardiac hypertrophy on coronary vasodilator reserve. Circulation Res. 51:1982;10-18.
51. Konstam M.A., Rousseau M.F., Kronenberg M.W., et al. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure SOLVD Investigators . Circulation. 86:1992;431-438.
52. Konstam M.A., Kronenberg M.W., Rousseau M.F., et al. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction SOLVD (Studies of Left Ventricular Dysfunction) Investigators . Circulation. 88:1993;2277-2283.
53. Pfeffer M.A., Lamas G.A., Vaughan D.E., et al. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 319:1988;80-86.
54. Bonarjee V.V., Carstensen S., Caidahl K., Nilsen D.W., Edner M., Berning J. Attenuation of left ventricular dilatation after acute myocardial infarction by early initiation of enalapril therapy CONSENSUS II Multi-Echo Study Group . Am J Cardiol. 72:1993;1004-1009.
55. Hall S.A., Cigarroa C.G., Marcoux L., Risser R.C., Grayburn P.A., Eichhorn E.J. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol. 25:1995;1154-1161.
56. Mukherjee S.K., Jaffe C.C. Left ventricular mass estimation by echocardiography is it clinically useful? Echocardiography. 12:1995;185-193.